Lung In the media

A study on estimated cancer mortality rates, published in the Annals of Oncology, found that lung cancer deaths in European women is set overtake breast cancer deaths within the next two to three years.

Since 2009, lung cancer death rates in women in Europe has increased by seven per cent, while breast cancer death rates in that same group have fallen by seven per cent. Currently, lung cancer kills more people in the UK than any other cancer. 

Women and lung cancer

One of the reasons cited for the increase, particularly in women, is that the peak time for smoking in women was in the 1960s – 20 years after the peak in male smoking. 

Lung cancer cases tend to reflect smoking rates two to three decades earlier, with about 80 per cent of cases being linked to tobacco. While lung cancer rates for men appear to be stabilising, those in women are steadily on the rise, according to the data.

There is hope that with fewer young European women now starting to smoke, this trend should reverse with time.

Early detection saves lives

The earlier that lung cancer is detected, the greater the chances of successful treatment. Currently, more than two-thirds of lung cancers are diagnosed at a late stage so survival rates for these patients are low. However, survival rates are higher the earlier diagnosis takes place. 

Lung cancer risk assessment clinic

Royal Brompton & Harefield Hospitals Specialist Care offers a lung cancer risk assessment clinic to private patients. The service is led by some of the UK’s leading specialists in respiratory medicine. The knowledge and expertise of these specialists and their teams are now available to anyone with concerns about their risk of lung cancer.


The following consultants offer lung cancer risk assessment clinics to private patients:

Professor Pallav Shah

Consultant physician in respiratory medicine




Professor Robert Wilson

Consultant physician in respiratory medicine




Professor Michael Polkey

Consultant respiratory physician